Does the media refer more to TMO or ANGO?

In the previous week, Thermo Fisher Scientific had 27 more articles in the media than AngioDynamics. MarketBeat recorded 38 mentions for Thermo Fisher Scientific and 11 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.32 beat AngioDynamics' score of 0.81 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 29 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ANGO or WST?

In the previous week, AngioDynamics had 1 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 11 mentions for AngioDynamics and 10 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.62 beat AngioDynamics' score of 0.81 indicating that West Pharmaceutical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive West Pharmaceutical Services 9 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor ANGO or SMA?

In the previous week, AngioDynamics had 3 more articles in the media than Smartstop Self Storage REIT. MarketBeat recorded 11 mentions for AngioDynamics and 8 mentions for Smartstop Self Storage REIT. Smartstop Self Storage REIT's average media sentiment score of 1.04 beat AngioDynamics' score of 0.81 indicating that Smartstop Self Storage REIT is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smartstop Self Storage REIT 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, ATRC or ANGO?

AtriCure has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 3.74 -$11.45M $0.21 187.33 AngioDynamics $320.17M 1.94 -$36.74M -$0.87 N/A

Is ATRC or ANGO more profitable?

AtriCure has a net margin of 1.85% compared to AngioDynamics' net margin of -11.48%. AtriCure's return on equity of 2.34% beat AngioDynamics' return on equity. Company Net Margins Return on Equity Return on Assets AtriCure 1.85% 2.34% 1.77% AngioDynamics -11.48% -5.73% -3.77%

Does the media prefer ATRC or ANGO?

In the previous week, AtriCure had 6 more articles in the media than AngioDynamics. MarketBeat recorded 17 mentions for AtriCure and 11 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 0.81 beat AtriCure's score of 0.47 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 8 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AngioDynamics 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ANGO or IART?

In the previous week, Integra LifeSciences had 5 more articles in the media than AngioDynamics. MarketBeat recorded 16 mentions for Integra LifeSciences and 11 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 0.81 beat Integra LifeSciences' score of 0.68 indicating that AngioDynamics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 7 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

AngioDynamics (ANGO) Competitors

$15.04 -0.15 (-0.99%)

Closing price 04:00 PM Eastern

Extended Trading

$15.04 0.00 (-0.03%)

As of 06:16 PM Eastern

Compare

ANGO vs. TMO, WST, SMA, ATRC, and IART

Should you buy AngioDynamics stock or one of its competitors? MarketBeat compares AngioDynamics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), and Integra LifeSciences (IART).

How does AngioDynamics compare to Thermo Fisher Scientific?

Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	4.79	$6.70B	$18.59	31.05
AngioDynamics	$320.17M	1.94	-$36.74M	-$0.87	N/A

In the previous week, Thermo Fisher Scientific had 27 more articles in the media than AngioDynamics. MarketBeat recorded 38 mentions for Thermo Fisher Scientific and 11 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.32 beat AngioDynamics' score of 0.81 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	29 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by company insiders. Comparatively, 6.0% of AngioDynamics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Thermo Fisher Scientific has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.33, indicating that its stock price is 67% less volatile than the broader market.

Thermo Fisher Scientific has a net margin of 15.04% compared to AngioDynamics' net margin of -11.48%. Thermo Fisher Scientific's return on equity of 17.09% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
AngioDynamics	-11.48%	-5.73%	-3.77%

Thermo Fisher Scientific presently has a consensus price target of $619.41, suggesting a potential upside of 7.31%. AngioDynamics has a consensus price target of $19.50, suggesting a potential upside of 29.65%. Given AngioDynamics' higher probable upside, analysts clearly believe AngioDynamics is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.79
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40

Summary

Thermo Fisher Scientific beats AngioDynamics on 13 of the 16 factors compared between the two stocks.

How does AngioDynamics compare to West Pharmaceutical Services?

AngioDynamics (NASDAQ:ANGO) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

AngioDynamics has a beta of 0.33, suggesting that its stock price is 67% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

In the previous week, AngioDynamics had 1 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 11 mentions for AngioDynamics and 10 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.62 beat AngioDynamics' score of 0.81 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	9 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 6.0% of AngioDynamics shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

AngioDynamics currently has a consensus price target of $19.50, suggesting a potential upside of 29.65%. West Pharmaceutical Services has a consensus price target of $368.08, suggesting a potential upside of 4.81%. Given AngioDynamics' higher probable upside, equities research analysts plainly believe AngioDynamics is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

West Pharmaceutical Services has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$320.17M	1.94	-$36.74M	-$0.87	N/A
West Pharmaceutical Services	$3.07B	8.04	$493.70M	$7.81	44.97

West Pharmaceutical Services has a net margin of 16.98% compared to AngioDynamics' net margin of -11.48%. West Pharmaceutical Services' return on equity of 20.11% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-11.48%	-5.73%	-3.77%
West Pharmaceutical Services	16.98%	20.11%	14.83%

Summary

West Pharmaceutical Services beats AngioDynamics on 14 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to Smartstop Self Storage REIT?

AngioDynamics (NASDAQ:ANGO) and Smartstop Self Storage REIT (NYSE:SMA) are related small-cap companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Smartstop Self Storage REIT has a net margin of 4.38% compared to AngioDynamics' net margin of -11.48%. Smartstop Self Storage REIT's return on equity of 1.00% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-11.48%	-5.73%	-3.77%
Smartstop Self Storage REIT	4.38%	1.00%	0.54%

89.4% of AngioDynamics shares are owned by institutional investors. 6.0% of AngioDynamics shares are owned by insiders. Comparatively, 5.7% of Smartstop Self Storage REIT shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Smartstop Self Storage REIT has lower revenue, but higher earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$320.17M	1.94	-$36.74M	-$0.87	N/A
Smartstop Self Storage REIT	$281.14M	6.68	-$1.55M	$0.15	226.19

In the previous week, AngioDynamics had 3 more articles in the media than Smartstop Self Storage REIT. MarketBeat recorded 11 mentions for AngioDynamics and 8 mentions for Smartstop Self Storage REIT. Smartstop Self Storage REIT's average media sentiment score of 1.04 beat AngioDynamics' score of 0.81 indicating that Smartstop Self Storage REIT is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smartstop Self Storage REIT	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AngioDynamics presently has a consensus target price of $19.50, indicating a potential upside of 29.65%. Smartstop Self Storage REIT has a consensus target price of $36.44, indicating a potential upside of 7.40%. Given AngioDynamics' higher probable upside, research analysts clearly believe AngioDynamics is more favorable than Smartstop Self Storage REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.70

AngioDynamics has a beta of 0.33, suggesting that its stock price is 67% less volatile than the broader market. Comparatively, Smartstop Self Storage REIT has a beta of 0.5, suggesting that its stock price is 50% less volatile than the broader market.

Summary

Smartstop Self Storage REIT beats AngioDynamics on 12 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to AtriCure?

AtriCure (NASDAQ:ATRC) and AngioDynamics (NASDAQ:ANGO) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

AtriCure has a net margin of 1.85% compared to AngioDynamics' net margin of -11.48%. AtriCure's return on equity of 2.34% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	1.85%	2.34%	1.77%
AngioDynamics	-11.48%	-5.73%	-3.77%

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 4.0% of AtriCure shares are owned by insiders. Comparatively, 6.0% of AngioDynamics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, AtriCure had 6 more articles in the media than AngioDynamics. MarketBeat recorded 17 mentions for AtriCure and 11 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 0.81 beat AtriCure's score of 0.47 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	8 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AngioDynamics	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure presently has a consensus price target of $48.50, indicating a potential upside of 23.28%. AngioDynamics has a consensus price target of $19.50, indicating a potential upside of 29.65%. Given AngioDynamics' higher possible upside, analysts clearly believe AngioDynamics is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.82
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40

AtriCure has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	3.74	-$11.45M	$0.21	187.33
AngioDynamics	$320.17M	1.94	-$36.74M	-$0.87	N/A

AtriCure has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.33, meaning that its share price is 67% less volatile than the broader market.

Summary

AtriCure beats AngioDynamics on 14 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to Integra LifeSciences?

AngioDynamics (NASDAQ:ANGO) and Integra LifeSciences (NASDAQ:IART) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

AngioDynamics has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$320.17M	1.94	-$36.74M	-$0.87	N/A
Integra LifeSciences	$1.64B	0.84	-$516.47M	-$0.09	N/A

Integra LifeSciences has a net margin of -0.44% compared to AngioDynamics' net margin of -11.48%. Integra LifeSciences' return on equity of 18.30% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-11.48%	-5.73%	-3.77%
Integra LifeSciences	-0.44%	18.30%	5.30%

In the previous week, Integra LifeSciences had 5 more articles in the media than AngioDynamics. MarketBeat recorded 16 mentions for Integra LifeSciences and 11 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 0.81 beat Integra LifeSciences' score of 0.68 indicating that AngioDynamics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	7 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 6.0% of AngioDynamics shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

AngioDynamics has a beta of 0.33, suggesting that its share price is 67% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market.

AngioDynamics currently has a consensus target price of $19.50, indicating a potential upside of 29.65%. Integra LifeSciences has a consensus target price of $18.86, indicating a potential upside of 6.66%. Given AngioDynamics' stronger consensus rating and higher probable upside, research analysts plainly believe AngioDynamics is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

Summary

AngioDynamics beats Integra LifeSciences on 10 of the 17 factors compared between the two stocks.

Get AngioDynamics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ANGO vs. The Competition

Export

Metric	AngioDynamics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$621.60M	$5.65B	$6.90B	$12.86B
Dividend Yield	N/A	1.78%	2.60%	10.00%
P/E Ratio	-17.29	23.39	280.82	25.41
Price / Sales	1.94	43.83	599.65	90.78
Price / Cash	48.49	32.60	72.11	49.40
Price / Book	3.64	6.03	12.95	6.08
Net Income	-$36.74M	$151.74M	$3.49B	$348.07M
7 Day Performance	2.80%	4.81%	3.57%	4.71%
1 Month Performance	14.90%	-0.15%	-2.50%	-2.12%
1 Year Performance	73.47%	8.50%	73.94%	20.58%

AngioDynamics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ANGO AngioDynamics	3.9347 of 5 stars	$15.04 -1.0%	$19.50 +29.7%	+75.2%	$621.60M	$320.17M	N/A	760	Analyst Revision
TMO Thermo Fisher Scientific	4.6814 of 5 stars	$586.01 +4.7%	$617.14 +5.3%	+20.8%	$217.77B	$44.56B	31.52	125,000	Positive News Analyst Forecast
WST West Pharmaceutical Services	3.9586 of 5 stars	$333.84 +1.7%	$364.42 +9.2%	+46.4%	$23.58B	$3.33B	42.74	10,800	Positive News Analyst Forecast
SMA Smartstop Self Storage REIT	3.2855 of 5 stars	$35.50 +1.0%	$36.44 +2.7%	-3.2%	$1.97B	$294.00M	236.63	N/A	Positive News Earnings Report
ATRC AtriCure	3.9999 of 5 stars	$38.44 +2.9%	$49.13 +27.8%	+7.3%	$1.94B	$534.53M	182.18	1,300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ANGO) was last updated on 8/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and IART

How does AngioDynamics compare to Thermo Fisher Scientific?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Summary

How does AngioDynamics compare to AtriCure?

Summary

How does AngioDynamics compare to Integra LifeSciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and IART

How does AngioDynamics compare to Thermo Fisher Scientific?

Which has better earnings and valuation, TMO or ANGO?

Does the media refer more to TMO or ANGO?

Do insiders and institutionals hold more shares of TMO or ANGO?

Which has more risk & volatility, TMO or ANGO?

Is TMO or ANGO more profitable?

Do analysts prefer TMO or ANGO?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Which has more risk and volatility, ANGO or WST?

Does the media favor ANGO or WST?

Do insiders and institutionals have more ownership in ANGO or WST?

Do analysts rate ANGO or WST?

Which has better valuation & earnings, ANGO or WST?

Is ANGO or WST more profitable?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Is ANGO or SMA more profitable?

Do insiders & institutionals believe in ANGO or SMA?

Which has preferable earnings & valuation, ANGO or SMA?

Does the media favor ANGO or SMA?

Do analysts rate ANGO or SMA?

Which has more risk & volatility, ANGO or SMA?

Summary

How does AngioDynamics compare to AtriCure?

Is ATRC or ANGO more profitable?

Do insiders & institutionals believe in ATRC or ANGO?

Does the media prefer ATRC or ANGO?

Do analysts recommend ATRC or ANGO?

Which has better earnings and valuation, ATRC or ANGO?

Which has more volatility and risk, ATRC or ANGO?

Summary

How does AngioDynamics compare to Integra LifeSciences?

Which has higher valuation & earnings, ANGO or IART?

Is ANGO or IART more profitable?

Does the media favor ANGO or IART?

Do insiders and institutionals have more ownership in ANGO or IART?

Which has more risk and volatility, ANGO or IART?

Do analysts rate ANGO or IART?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools